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Available online at www.sciencedirect.comLong-term potentiation of synaptic strength (LTP) in
nociceptive pathways shares principle features with
hyperalgesia including induction protocols, pharmacological
profile, neuronal and glial cell types involved and means for
prevention. LTP at synapses of nociceptive nerve fibres
constitutes a contemporary cellular model for pain
amplification following trauma, inflammation, nerve injury or
withdrawal from opioids. It provides a novel target for pain
therapy. This review summarizes recent progress which has
been made in unravelling the properties and functions of LTP in
the nociceptive system and in identifying means for its
prevention and reversal.
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Introduction
The vulnerability of tissues rises significantly in case of an
injury or an inflammation. The nociceptive systems adapts
to this by lowering response thresholds and by increasing
response magnitude in order to maintain its protective
function [1]. Behaviourally these adaptations manifest as
hyperalgesia in experimental animals [2,3], in volunteers
[4] and in patients [5]. Pro-nociceptive adaptations may
occur at all levels of the neuraxis from nociceptive nerve
endings, to spinal dorsal horn and all the way up to cortical
neuronal networks. In contrast to sensitization of nocicep-
tive nerve endings, some of the central mechanisms may
persist long after the initial cause for pain and the need for
special tissue protection has disappeared. Hyperalgesia
then becomes maladaptive. The underlying central mech-
anisms can be grouped into two major categories: Impaired
inhibition and enhanced excitation in nociceptive path-
ways. Multiple mechanisms have been identified so far
which relate to the synthesis and/or the release of neuro-
transmitters, the density, the distribution and the acti-
vation of neurotransmitter receptors, the single channel
Open access under CC BY-NC-ND license. Current Opinion in Pharmacology 2012, 12:18–27 conductance or the open time probability of ion channels
and the number and morphology of synapses and dendritic
spines. All of which can ultimately modulate the neurons’
intrinsic properties or synaptic strength.
From early on important insights into central components
of hyperalgesia have been obtained in humans [6], from
reflex measurements in experimental animals, for
example [7], as well as from single neuron recordings
in ventral- [8] and more importantly in the dorsal horn [9]
of the spinal cord. It was only in later studies that synaptic
plasticity has been assessed in the nociceptive system
[10,11].
Nociceptive neurons are defined by their input (i.e. the
excitatory mono- or polysynaptic input from nociceptive
nerve fibres), but not by their function. Consequently
nociceptive neurons comprise a very heterogeneous
group of neurons including excitatory and inhibitory
interneurons, projection neurons and motoneurons.
Changes in the responsiveness of nociceptive neurons
may thus have different and even opposing effects on
pain depending upon the neurons’ function. For better
understanding, here, the term ‘Principle Pain Neurons’ is
used for neurons which, when discharging action poten-
tials, trigger the perception of pain (see discussion in
[12]). Here we review recent progress in understanding
synaptic plasticity in spinal nociceptive pathways which,
when expressed in principle pain neurons, amplify pain.
The focus is on most recently published data. Compre-
hensive reviews on the synaptic mechanisms of hyper-
algesia have been published [3,13].
Activity-dependent LTP at the first synapse in
nociceptive pathways
Hyperalgesia and LTP are induced in an activity-de-
pendent manner by strong or lasting discharges in C-
fibres generating a central amplification of nociceptive
responses. Typically LTP is induced by conditioning
high frequency electrical stimulation (100 Hz; HFS,
Figure 1A) at most synapses in the central nervous system
and also at C-fibre synapses in the superficial spinal dorsal
horn [14]. At C-fibre synapses LTP can further be
induced by conditioning low frequency stimulation
(2–10 Hz, LFS, Figure 1B) [15], but also by natural
noxious stimulation (subcutaneous capsaicin, Figure 1C,
formalin, noxious heat or pinching) and by acute nerve
injury (sciatic nerve transection or crush) [15–17]. LTP
has been demonstrated in vivo and in vitro, mainly in rats
(e.g. [18,19,–21,22,23,24,25,26,27,28] for recent stu-
dies) but also in mice [29]. As a general rule, conditioning
stimuli which induce LTP at C-fibre synapses also causewww.sciencedirect.com
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Induction of LTP at C-fibre synapses.
The figure illustrates different activity-dependent and -independent forms of LTP at C-fibre synapses. The graphs display mean time courses of
amplitudes of C-fibre-evoked field potentials measured in the superficial spinal dorsal horn of adult, deeply anaesthetized rats. Field potentials were
evoked by stimulation of sciatic nerve fibres at C-fibre intensity. Conditioning stimulation consisted of electrical stimulation of sciatic nerve fibre
afferents at a high frequency (A, HFS, 100 Hz given four times for 1 s at 10 s intervals), at a low frequency (B, LFS, 2 Hz for 2 min), or subcutaneous
injection of transient receptor potential vanilloid 1 channel agonist capscaicin (C, 1%, 100 ml). In D LTP was induced upon withdrawal from a brief (1 h)
intravenous application of a high dose of remifentanil (450 mg kg1 h1 for 1 h, black horizontal bar). Modified from [15,18].hyperalgesia in behaving animals or human subjects (see
below and [3,13] for reviews).
While LTP can be induced at most, if not all synapses in
the central nervous system, the susceptibility for LTP
induction and suitable parameters for LTP induction vary,
however, considerably. A good example are synapses of
nociceptive skin afferents which are apparently less prone
to express LTP as compared to synapses from muscle
afferents [26]. Conditioning stimulation of C-fibre affer-
ents which innervate the skin may fail to induce LTP while
identical conditioning stimulation of afferents in a mixed
nerve or in a muscle nerve induces robust LTP [26]. Thiswww.sciencedirect.com difference disappears when brain-derived neurotrophic
factor (BDNF) is applied directly onto the spinal cord at
a low concentration suggesting that lack of this neuro-
trophic factor in cutaneous afferents renders them less
prone to express LTP. The differential susceptibility of
skin versus muscle afferents to express LTP correlates well
with their respective ability to trigger prolonged facilitation
of nociceptive reflexes [30].
Activity-independent forms of LTP
Opioid withdrawal LTP Hyperalgesia and spinal LTP can
also be induced in the absence of any activity in nociceptive
nerve fibres. A clinically relevant example is hyperalgesiaCurrent Opinion in Pharmacology 2012, 12:18–27
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Hyperalgesia by synaptic long-term potentiation Sandku¨hler and Gruber-Schoffnegger 21which develops after abrupt withdrawal from opioids. This
form of hyperalgesia may also involve expression of LTP at
C-fibresynapses [18].Abriefapplication of theultra-short
acting m-opioid receptor (MOR) agonist remifentanil in
vivo or D-Ala2, N-MePhe4, Gly-ol]-enkephalin (DAMGO)
in vitro leads to an acute depression of synaptic strength in
C-fibres (Figure 1D). Upon withdrawal synaptic strength
not only quickly returns to normal but becomes potentiated
for prolonged periods of time (Figure 1D). The induction
of withdrawal LTP at C-fibre synapses in vitro [18]
requiresactivation ofpostsynapticG-proteins,postsynaptic
NMDA-receptors and a rise in postsynaptic Ca2+ levels
[18]. Some MOR agonists activate additional pro-
nociceptive mechanisms. For example, withdrawal from
fentanyl or morphine not only causes opioid withdrawal
LTP but in addition activates descending, facilitatory,
serotonergic pathways acting on spinal 5-HT3 receptors
[31]. Hyperalgesia results when descending facilitation
and/or opioid withdrawal LTP are expressed at synapses
between nociceptive C-fibres and principle pain neurons.
Other activity-independent forms of LTP are induced at C-
fibre synapses by spinal application of BDNF [20], ade-
nosine triphosphate (ATP) [27] or reactive oxygen species
donors [24] and in nerve injured rats also by tumour
necrosis factor-a (TNFa) [32].
Distinct signalling pathways for LTP induction
versus LTP maintenance
The signalling pathways which are involved in the induc-
tion of LTP are different from those which are required
for its maintenance. They further differ between differ-
ent induction protocols for spinal LTP which are
expressed at C-fibre synapses, see Figures 2 and 3.
Postsynaptic signalling for LTP induction
Virtually all known forms of LTP induction at spinal C-
fibre synapses require a rise in postsynaptic Ca2+ concen-
tration [14,15,18]. Postsynaptic Ca2+ rises by opening of
postsynaptic NMDA receptors [14], T-type voltage-gated
calcium channels [15], Ca2+-permeable AMPA receptors( Figure 2 Legend ) Signalling pathways of LTP induction at C-fibre synapse
The schemes summarize elements of the signalling pathways which are requi
The elements involved in LTP induction are typically identified by the respec
were applied topically to the spinal cord. Many of the involved signalling elem
The cellular site(s) of action is/are thus in most cases not known, except when
for Ca2+, NMDAR, and GPCR (which are in boxes here) in A. Suggested signa
by dotted lines. * indicates that activation of this element induces LTP in sp
Abbreviations and literature:
AMPAR: a-amino-3-3hydroxy-5-5methyl-4-4isoxazoleproprionic acid recepto
neurotrophic factor [20,34]; CaMKII: calcium/calmodulin-dependent protein kin
receptor [29,75]; ERK: Extracellular signal-regulated kinase [76]; GLT-1: Gluta
Inositol triphosphate receptor [14,15]; mGluR1: Metabotropic glutamate recep
Neurokinin 2 receptor [80,81]; NMDAR: N-methyl D-aspartate receptor [11,14–1
PKA: Protein kinase A [73]; PKC: Protein kinase C [15,18,19,73]; PLC: Phosp
p38MAPK: p38 mitogen-activated protein kinases [20,27]; ROS: Reactive oxy
kinases [25]; TNFa: Tumour necrosis factor a [25,32]; TNFaR: Tumour necros
type 2 [20]; T-type VGCC: T-type voltage gated calcium channel [14,15,19]; 5
www.sciencedirect.com [33] and by Ca2+ release from intracellular Ca2+ stores
triggered by activation of metabotropic glutamate recep-
tors or neurokinin 1 receptors [19]. Metabotropic recep-
tors mobilise intracellular Ca2+ by activation of ryanodine
and inositol-1,4,5 trisphosphate (IP3) receptors via phos-
pholipase C [19], see Figure 2A. The rise in postsynaptic
Ca2+ then activates Ca2+-dependent signalling pathways
involving protein kinase C (PKC), calcium-calmodulin-
dependent protein kinase II (CaMKII) and nitric oxide
synthase (NOS) [15]. Other enzymes involved are extra-
cellular signal-regulated kinase (ERK) which induces a
lasting phosphorylation and activation of the transcription
factor cAMP responsive element-binding protein
(CREB), see Figure 2A [34].
Not all forms of spinal LTP require the activation of all of
these signalling elements for induction. For example,
LTP induced by spinal application of ATP or BDNF
[27,34], but not high frequency stimulation-induced LTP
[32] depends upon p38 mitogen-activated protein kinase
(p38 MAPK). Likewise, high- and low frequency stimu-
lation-induced LTP [15,19] but not opioid-withdrawal
LTP [18] requires activation of CaMKII.
Pre- and postsynaptic signalling for LTP maintenance
While the induction of all known forms of LTP at spinal C-
fibre synapses requires postsynaptic signalling, recent stu-
diessuggest that themaintenanceofLTPmay involveboth,
post- as well as presynaptic signalling, see Figure 3A. The
early phase of LTP consists of the first few hours of LTP
expression. Early phase LTP involves posttranslational
modifications of synaptic proteins, such as phosphorylation
of synaptic AMPA receptors [35]. Conditioning LFS of
primary afferent C-fibres induces phosphorylation of the
GluR1 subunit of spinal AMPA receptor channels at Ser831
[36] which increases their unitary single channel conduc-
tance. AMPA receptor-mediated currents in spinal nocicep-
tive neurons are further elevated by enhanced AMPA
receptor expression and by modified trafficking [35]. AMPA
receptors are largely located postsynaptically where they
mediate neuronal excitation. AMPA receptors may also bes.
red (A) or sufficient (B) for the induction of LTP at spinal C-fibre synapses.
tive blockers (required elements) or activators (sufficient elements) which
ents are expressed at more than one cellular site as shown in the figure.
 substances were applied directly into the postsynaptic neuron as shown
lling pathways are indicated by arrows. Diffusion of elements is illustrated
inalised animals only.
r [72]; ATP: Adenosine triphosphate [22,27]; BDNF: Brain derived
ase II [15,18,19,73]; D1,5R: Dopamine receptor D1,5 [74]; EphB: Ephrin B
mate transporter 1 [77]; GPCR: G-protein coupled receptor [18]; IP3R:
tor group 1 [78,79]; NK1R: Neurokinin 1 receptor [14,15,19,80,81]; NK2R:
6,18,19,81]; NO: Nitric oxide [15,65]; NOS: Nitric oxide synthase [15,65];
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gen species [24]; RyR: Ryanodine receptor [18,19,21]; SFK: Src family
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Figure 3
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Hyperalgesia by synaptic long-term potentiation Sandku¨hler and Gruber-Schoffnegger 23expressed at or near the terminals of a subset of dorsal root
ganglion cells where they, by contrast, mediate presynaptic
inhibition but not facilitation [37]. Taken together these
findings suggest a postsynaptic component to LTP main-
tenance via enhanced AMPA receptor function.
By contrast, H.-L. Pan and his colleagues concluded from
their data [38] that both, the induction and the mainten-
ance of opioid withdrawal LTP at unidentified synapses
in spinal dorsal horn is presynaptic. We provided, how-
ever, evidence that the induction of withdrawal LTP is
postsynaptic at C-fibre synapses [18], see paragraph
above and our eLetter to their report. After any postsyn-
aptic induction the expression of LTP may, nonetheless,
involve presynaptic mechanisms. And indeed upon with-
drawal from fentanyl or morphine but not from remifen-
tanil the paired-pulse ratio of C-fibre-evoked field
potentials decreases suggesting an increased neurotrans-
mitter release [31]. At synapses in the brain protein
kinase M z (PKMz) is one of the key factors responsible
for the maintenance of LTP [39]. Recent studies suggest
that this kinase is also required for plasticity in nocicep-
tive pathways in the spinal cord [40] and in the anterior
cingulate cortex [41]. It is presently unknown whether
PKMz is also involved in the maintenance of LTP at C-
fibre synapses.
Late phase LTP develops slowly over the first hours after
LTP induction and persists for days, weeks or even
longer. Expression of late phase LTP requires synapse-
to-nucleus signalling via signalling molecules such as
ERK1/2 and cAMP all of them may trigger the activation
of CREB. The transcription factor CREB controls the
expression of a myriad of proteins, many of which are
relevant for synaptic transmission. Late phase LTP can
consequently be blocked by protein synthesis inhibitors
[34] and may involve incorporation of new AMPA recep-
tors into the postsynaptic membrane [42], see Figure 2B
and [13,43,44] for recent reviews.
Role of glial cells for LTP induction
In the central nervous system neurons and glial cell
heavily interact and mutually influence their functions( Figure 3 Legend ) Signalling pathways of LTP maintenance and LTP rever
The schemes summarize elements of signalling pathways which are required 
these elements is blocked established LTP diminishes or disappears (requir
elements which, when activated reverse established LTP. These sufficient e
underlined are required for the reversal of LTP. When blocked these elemen
Blockers and activators of the respective elements were usually applied top
expressed at more than one cellular site as shown in the figure. The cellular s
pathways are indicated by arrows. Diffusion of elements is illustrated by do
Abbreviations and literature:
AMPAR: a-amino-3-3hydroxy-5-5methyl-4-4isoxazoleproprionic acid recept
receptor [84]; a2d VGCC: Voltage gated calcium channel [85]; CaMKII: Calciu
monophosphate [84]; D1,5R: Dopamine receptor D1,5 [74]; ERK: Extracellular 
[57]; mAChR: Muscarinic acetylcholine receptor [84]; mGluR1: Metabotropic
NMDAR: N-methyl D-aspartate receptor (unpubl.); NO: Nitric oxide [84]; NOS:
[73]; PP1: Protein phosphatase 1 (unpubl.); RyR: Ryanodine receptor (unpub
www.sciencedirect.com [45]. This also applies to the nociceptive system where
excitation of nociceptive nerve fibres not only activates
spinal neurons but also spinal microglia and astrocytes
which, in turn, release neuroactive substances [46]. The
release of these gliotransmitters  contributes to the induc-
tion and perhaps also to the maintenance of LTP at C-
fibres, see Figures 2A, B, 3A, and B. For example, HFS-
induced LTP can be prevented by blocking or silencing
spinal P2X7 receptors which are largely expressed on
microglia [22]. Activated glial cells, Src-family kinases
and p38 MAPK all contribute to the induction of LTP at
C-fibre synapses via release of TNFa and activation of
TNF receptor-1 [25]. In the absence of any C-fibre
activation, spinal application of BDNF [20] induces
late-phase LTP which requires activation of spinal
microglia, Src-family kinases and p38 MAPK, see Figure
2A, B. This will consequently induce the release of
TNFa, interleukin-1 and interleukin-6, among others
[47,48].
Is spinal LTP homo- or heterosynaptic in
nature?
Activity-dependent LTP may not only affect synapses
which were activated by the conditioning stimulus. LTP
may also ‘spread’ to inactive synapses converging onto the
same postsynaptic neuron. It is still unknown if LTP in
nociceptive pathways is homosynaptic in nature. Homo-
synaptic LTP at nociceptive synapses with principle pain
neurons leads to primary hyperalgesia. Heterosynaptic
LTP at synapses between nociceptive afferents and
principle pain neurons would cause pain amplification
outside but close to the area of injury or inflammation,
that is, secondary hyperalgesia. A recent study by Carole
Torsney [49] suggests that hindpaw inflammation by
complete Freund’s adjuvant leads to a heterosynaptic
facilitation of monosynaptic Ad-fibre input to spinal
lamina I neurons expressing the neurokinin-1 receptor.
This finding could well explain heterosynaptic mechan-
isms underlying mechanical hyperalgesia. Ongoing stu-
dies in our laboratory further suggest that in superficial
spinal dorsal horn homo- and heterosynaptic forms of
LTP are expressed at C-fibre- and GABAergic synapses,
respectively [50].sal at C-fibre synapses.
for the maintenance of LTP at spinal C-fibre synapses. Thus, when any of
ed elements for LTP maintenance, A). The diagram in B summarizes
lements for the reversal of LTP are underlined. Elements which are not
ts prevent the reversal of LTP by at least one of the sufficient elements.
ically to the spinal cord. Many of the known signalling elements are
ite(s) of action is/are thus not known in most cases. Suggested signalling
tted lines.
or (unpubl.); A1R: Adenosine 1 receptor [83]; a2-AR: a2-adrenergic
m/calmodulin-dependent protein kinase II [73]; cGMP: Cyclic guanosine
signal-regulated kinase [76,86]; GABAAR: g-aminobutyric acid A receptor
 glutamate receptor group 1 (unpubl.); MOR: m-opioid-receptor [85];
 Nitric oxide synthase [84] PKA: Protein kinase A [73]; PKC: Protein kinase
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24 NeurosciencesPrevention of LTP induction in nociceptive
pathways
Previous studies have identified a growing number of
targets for preventing LTP induction [13]. Clinically
useful tools for preventing LTP induction include
NMDA receptor antagonists, for example, [11,15,51],
opioids [52,53] and the noble gas xenon [54]. NMDA
receptor antagonists proved effective also in volunteers
[55]. The inducibility of spinal LTP is further modulated
by descending systems originating from various brain
sites. When descending pathways are interrupted con-
ditioning stimuli which are normally ineffective may now
induce LTP [16] indicating a pre-emptive function of
endogenous antihyperalgesic systems. These include
descending oxytocinergic hypothalamic pathways from
the paraventricular nucleus [56]. The induction of LTP
thus not only depends upon the parameters of condition-
ing stimulation and the type of afferent fibres involved,
but also upon the modulation by endogenous pro- and
antinociceptive systems.
Reversal of established LTP in nociceptive
pathways
LTP at synapses between nociceptive nerve fibres and
principle pain neurons causes hyperalgesia. Reversal of
LTP, that is, ‘depotentiation’ thus constitutes a potential
means to erase a memory trace of pain. When benzo-
diazepines are applied directly onto the spinal cord during
early phase LTP its consolidation is impaired [57], see
Figure 3B. A brief (1 h), systemic application of a high
dose of the ultra-short acting MOR agonist remifentanil
reverses LTP induced by low- or high-frequency
conditioning stimulation of C-fibre afferents or by sub-
cutaneous capsaicin [36]. The opioid-induced depoten-
tiation involves activation of NMDA receptors,
metabotropic glutamate receptors, Ca2+ release from rya-
nodine-sensitive intracellular stores and activation of
protein phosphatase 1, see Figure 3B. AMPA receptor
channels are phosphorylated at Ser831 by LTP-inducing
stimuli. This leads to enhanced single channel conduc-
tance and thus synaptic strength. AMPA receptors are
dephosphorylated at Ser831 by protein phosphatase 1
after high dose opioid administration. This probably
constitutes a key mechanism for opioid-induced depo-
tentiation [36]. Thus, in contrast to current believes
opioids may not only temporarily dampen pain, they
may also eliminate an important cause for hyperalgesia.
Hyperalgesia resulting from a biological
cascade amplifier in a nociceptive daisy chain
LTP is a form of synaptic plasticity which can be induced
at many different, it not all types of excitatory and
inhibitory synapses in the central nervous system. It is
thus not surprising that LTP is not only expressed at the
first synaptic relays in nociceptive pathways [14,15,18].
LTP has also been observed at synapses of glutamatergic
[28] and GABAergic [50] interneurons in superficial spinalCurrent Opinion in Pharmacology 2012, 12:18–27 dorsal horn and at excitatory synapses between neurons in
the spinal trigeminal subnucleus caudalis and -oralis [58].
Furthermore, LTP can be elicited at synapses in puta-
tively nociceptive relays in the anterior cingulate cortex
[59–61]. When LTP is simultaneously expressed at
multiple sites connected serially along excitatory nocicep-
tive pathways it will boost nociception exponentially. In
the first instance trauma or inflammation trigger sensit-
ization of nociceptors [1]. The resulting enhanced,
ongoing discharges in nociceptive nerve fibres induce
LTP at the first synaptic relays [3,13]. An obvious out-
come of LTP at excitatory synapses is the increased firing
of action potentials of the postsynaptic neuron in response
to presynaptic activity. LTP-inducing stimuli indeed lead
to elevated C-fibre-evoked discharges in dorsal horn
neurons, see [56,62,63] for recent studies. This in turn
will probably facilitate LTP induction at synapses further
downstream in nociceptive pathways [61]. And indeed,
conditioning, LTP-inducing stimulation of sciatic nerve
fibres causes enhanced positron-emission tomography
signals in the primary somatosensory cortex and delayed
responses in the amygdala, the periaqueductal grey, the
rostral ventromedial medulla, and the dorsolateral ponto-
mesencephalic tegmentum [64]. Such a sequence of
events constitutes a biological cascade amplifier in a
nociceptive daisy chain.
Behavioural correlates of LTP in nociceptive
pathways
Conditioning stimuli which induce LTP at spinal C-fibre
synapses lead to hyperalgesia in behaving animals. Under
local muscular paralysis with lidocaine, brief conditioning
HFS of sciatic nerve fibre afferents at C-fibre strength
leads to thermal [65] and to mechanical [66] hyperalgesia
for 6–9 days at the ipsilateral but not at the contralateral
hindpaw.
The final proof for any pain mechanism is a perceptual
correlate in the human subject. In volunteers, transcu-
taneous conditioning HFS of cutaneous nerve fibres
induces a long-lasting increase in pain sensitivity at the
stimulation site (homotopic facilitation) as well as in the
immediately surrounding skin area (heterotopic facili-
tation) [67]. A number of recent studies have confirmed
and extended the initial reports of perceptual [55,68–70]
and electrophysiological [71] correlates of spinal LTP in
volunteers, see [3,13] for reviews. At present a direct
comparison between the results obtained from exper-
imental animals with those from human subjects is,
however, hampered by the fact that in humans condition-
ing stimulation was always applied to a small set of
cutaneous afferents, while in most previous animal exper-
iments conditioning electrical nerve stimulation recruited
virtually all fibres in large mixed nerves, thus including
muscle afferents. This probably makes a major difference
as muscle and skin afferents differ substantially in their
ability to express synaptic LTP [26]. Nonetheless thewww.sciencedirect.com
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tual correlates of LTP can be demonstrated in humans
and they are probably also relevant for pain in patients.
Concluding remarks
LTP is a feature of most, if not all synapses in the central
nervous system but its properties much depend on the
type of synapse involved, the induction protocols used
and the context of its induction. LTP at C-fibre synapses
constitutes a powerful model system for the prolonged
amplification of nociception. LTP probably contributes
to enhanced pain-related behaviour in experimental
animals and to the amplification of pain perception in
human subjects. Understanding LTP in nociceptive
pathways appears to be promising for developing better
strategies for the prevention and the treatment of some
types of chronic pain.
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